S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   143.10 (+2.90%)
MSFT   227.27 (+0.58%)
FB   274.30 (-0.07%)
GOOGL   1,876.76 (-0.83%)
AMZN   3,290.45 (-0.05%)
TSLA   875.71 (+3.43%)
NVDA   538.67 (-1.79%)
BABA   261.29 (+1.03%)
CGC   33.55 (-0.74%)
GE   10.99 (-1.08%)
MU   80.69 (-1.93%)
AMD   93.65 (+0.93%)
NIO   62.23 (+0.45%)
T   28.98 (+0.17%)
F   11.07 (-3.91%)
ACB   10.50 (-1.41%)
BA   201.37 (-2.17%)
DIS   170.64 (-1.24%)
NFLX   557.07 (-1.43%)
GILD   67.35 (+0.61%)
S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   143.10 (+2.90%)
MSFT   227.27 (+0.58%)
FB   274.30 (-0.07%)
GOOGL   1,876.76 (-0.83%)
AMZN   3,290.45 (-0.05%)
TSLA   875.71 (+3.43%)
NVDA   538.67 (-1.79%)
BABA   261.29 (+1.03%)
CGC   33.55 (-0.74%)
GE   10.99 (-1.08%)
MU   80.69 (-1.93%)
AMD   93.65 (+0.93%)
NIO   62.23 (+0.45%)
T   28.98 (+0.17%)
F   11.07 (-3.91%)
ACB   10.50 (-1.41%)
BA   201.37 (-2.17%)
DIS   170.64 (-1.24%)
NFLX   557.07 (-1.43%)
GILD   67.35 (+0.61%)
S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   143.10 (+2.90%)
MSFT   227.27 (+0.58%)
FB   274.30 (-0.07%)
GOOGL   1,876.76 (-0.83%)
AMZN   3,290.45 (-0.05%)
TSLA   875.71 (+3.43%)
NVDA   538.67 (-1.79%)
BABA   261.29 (+1.03%)
CGC   33.55 (-0.74%)
GE   10.99 (-1.08%)
MU   80.69 (-1.93%)
AMD   93.65 (+0.93%)
NIO   62.23 (+0.45%)
T   28.98 (+0.17%)
F   11.07 (-3.91%)
ACB   10.50 (-1.41%)
BA   201.37 (-2.17%)
DIS   170.64 (-1.24%)
NFLX   557.07 (-1.43%)
GILD   67.35 (+0.61%)
S&P 500   3,839.77 (-0.04%)
DOW   30,795.18 (-0.65%)
QQQ   328.89 (+1.07%)
AAPL   143.10 (+2.90%)
MSFT   227.27 (+0.58%)
FB   274.30 (-0.07%)
GOOGL   1,876.76 (-0.83%)
AMZN   3,290.45 (-0.05%)
TSLA   875.71 (+3.43%)
NVDA   538.67 (-1.79%)
BABA   261.29 (+1.03%)
CGC   33.55 (-0.74%)
GE   10.99 (-1.08%)
MU   80.69 (-1.93%)
AMD   93.65 (+0.93%)
NIO   62.23 (+0.45%)
T   28.98 (+0.17%)
F   11.07 (-3.91%)
ACB   10.50 (-1.41%)
BA   201.37 (-2.17%)
DIS   170.64 (-1.24%)
NFLX   557.07 (-1.43%)
GILD   67.35 (+0.61%)
Log in
NYSE:ABC

AmerisourceBergen Stock Forecast, Price & News

$106.90
-0.86 (-0.80 %)
(As of 01/25/2021 10:50 AM ET)
Add
Compare
Today's Range
$106.18
Now: $106.90▼
$107.48
50-Day Range
$96.50
MA: $101.33▼
$110.13
52-Week Range
$72.06
Now: $106.90▼
$112.48
Volume6,006 shs
Average Volume1.71 million shs
Market Capitalization$21.83 billion
P/E RatioN/A
Dividend Yield1.63%
Beta0.57
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
AmerisourceBergen logo

MarketRank™

Overall MarketRank™

1.88 out of 5 stars

Medical Sector

96th out of 1,923 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 14 stocks

Analyst Opinion: 2.3Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNYSE:ABC
Previous Symbol
CUSIP03073E10
CIK1140859
Webwww.amerisourcebergen.com
Phone610-727-7000
Employees22,000
Year FoundedN/A

Debt

Debt-to-Equity Ratio0.91
Current Ratio0.98
Quick Ratio0.60

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio12.76
P/E Growth1.13

Sales & Book Value

Annual Sales$189.89 billion
Price / Sales0.11
Cash Flow$10.00 per share
Price / Cash Flow10.69
Book Value($4.11) per share
Price / Book-26.01

Profitability

EPS (Most Recent Fiscal Year)$7.90
Net Income$-3,408,720,000.00
Net Margins-1.80%
Return on Equity65.93%
Return on Assets3.91%

Miscellaneous

Outstanding Shares204,250,000
Market Cap$21.83 billion
Next Earnings Date2/4/2021 (Confirmed)
OptionableOptionable
$106.90
-0.86 (-0.80 %)
(As of 01/25/2021 10:50 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

How has AmerisourceBergen's stock been impacted by COVID-19?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ABC stock has increased by 25.5% and is now trading at $106.63.
View which stocks have been most impacted by COVID-19.

Is AmerisourceBergen a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AmerisourceBergen?

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for AmerisourceBergen.

How can I listen to AmerisourceBergen's earnings call?

AmerisourceBergen will be holding an earnings conference call on Thursday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) announced its quarterly earnings results on Tuesday, November, 10th. The company reported $1.89 earnings per share for the quarter, beating analysts' consensus estimates of $1.87 by $0.02. The business had revenue of $49.24 billion for the quarter, compared to analysts' expectations of $47.93 billion. AmerisourceBergen had a negative net margin of 1.80% and a positive trailing twelve-month return on equity of 65.93%. The business's quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the business posted $1.61 earnings per share.
View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Thursday, January 14th. Shareholders of record on Friday, February 12th will be paid a dividend of $0.44 per share on Monday, March 1st. This represents a $1.76 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend is Thursday, February 11th.
View AmerisourceBergen's dividend history.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.63%. AmerisourceBergen does not yet have a strock track record of dividend growth. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 18.78% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY21 earnings guidance on Wednesday, January, 6th. The company provided earnings per share (EPS) guidance of $8.25-8.50 for the period, compared to the Thomson Reuters consensus estimate of $8.41.

What price target have analysts set for ABC?

9 Wall Street analysts have issued 12 month price objectives for AmerisourceBergen's shares. Their forecasts range from $88.00 to $140.00. On average, they expect AmerisourceBergen's share price to reach $114.44 in the next year. This suggests a possible upside of 7.3% from the stock's current price.
View analysts' price targets for AmerisourceBergen or view Wall Street analyst' top-rated stocks.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of ABC's competitors.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 60, Pay $3.31M)
  • Mr. James F. Cleary Jr., Exec. VP & CFO (Age 58, Pay $1.35M)
  • Ms. Gina K. Clark, Exec. VP and Chief Communications & Admin. Officer (Age 64, Pay $1.07M)
  • Mr. John G. Chou, Exec. VP & Chief Legal Officer (Age 65, Pay $1.41M)
  • Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 54, Pay $1.44M)
  • Mr. Lazarus Krikorian, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 56)
  • Bennett S. Murphy, Sr. VP of Investor Relations
  • Ms. Kathy H. Gaddes, Exec. VP & Chief Compliance Officer (Age 58)
  • Ms. Silvana Battaglia, Exec. VP & Chief HR Officer (Age 54)
  • Ms. Leslie E. Donato, Exec. VP & Chief Strategy Officer (Age 52)

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.14%), DNB Asset Management AS (0.05%), Hexavest Inc. (0.03%), Pineno Levin & Ford Asset Management Inc. (0.03%), Pendal Group Limited (0.03%) and Cypress Capital Group (0.02%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Richard W Gochnauer, Robert P Mauch and Steven H Collis.
View institutional ownership trends for AmerisourceBergen.

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Crossmark Global Holdings Inc., TCI Wealth Advisors Inc., DNB Asset Management AS, CX Institutional, Cypress Capital Group, Bowling Portfolio Management LLC, and Donald L. Hagan LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen or view top insider-selling stocks.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was bought by a variety of institutional investors in the last quarter, including Pendal Group Limited, Kestra Advisory Services LLC, Pacer Advisors Inc., Exchange Traded Concepts LLC, Journey Advisory Group LLC, Prairiewood Capital LLC, Wedge Capital Management L L P NC, and NuWave Investment Management LLC. Company insiders that have bought AmerisourceBergen stock in the last two years include Dermot Mark Durcan, and James F Cleary Jr.
View insider buying and selling activity for AmerisourceBergen or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $106.63.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $21.78 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis. AmerisourceBergen employs 22,000 workers across the globe.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.